MolNFT v1 · #187428 · protein
Crystal structure of human fibrillarin in complex with S-adenosyl-L- methionine
7SE7 · RRNA 2'-O-methyltransferase fibrillarin: “Crystal structure of human fibrillarin in complex with S-adenosyl-L- methionine”. X-ray diffraction, 1 ligand (SAM), 1 pocket (best druggability 0.46). MolNFT v1 #187428 on GenesisL1: 3D…
- PDB
- 7SE7
- Type
- protein
- Length
- 229 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- RRNA 2'-O-methyltransferase fibrillarin
- EC
- 2.1.1.-
- UniProt
- P22087
- Ligands
- SAM
- Pockets
- 1 · best druggability 0.46
Structure
x-ray diffraction · 1 distinct chain · 29% helix, 31% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | RRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) | protein | 229 | 29% helix, 31% strand | P22087 |
Ligands and binding sites
- SAM · S-adenosylmethionine · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 112 | 0.46 | 0.79 | 25 | SAM |
Compared structures
- 7SE7 · Crystal structure of human Fibrillarin in complex with S-adenosyl-L-methionine · the same entry in another collection · chain A against A, TM-score 1.00
- P22087 · AlphaFold monomer V2.0 prediction for rRNA 2'-O-methyltransferase fibrillarin (P22087) · a predicted model of the same protein · chain A against A, TM-score 0.97
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P22087
- Elsewhere: RCSB PDB 7SE7 · PDBe 7SE7 · UniProt P22087
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.